Ipamorelin 10mg

Ipamorelin 10mg

$93.00

Ipamorelin is a selective growth hormone secretagogue designed to stimulate the release of growth hormone (GH) while minimizing effects on other hormones. Known for its targeted action, Ipamorelin has shown promising potential in promoting muscle growth, enhancing bone density, and supporting fat loss. Additionally, research highlights its ability to improve sleep quality and accelerate recovery from exercise-induced muscle damage, making it a valuable tool in performance optimization and overall wellness.

Category:

Description

Referenced Citations

  1. Raun, K., et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 139(5), 552-561. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/9849822/
  2. Sinha, D.K., et al. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational Andrology and Urology, 9(Suppl 2), S149-S159. [Online].
    Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108996/
  3. Beck, D.E., et al. (2014). Efficacy of Ipamorelin, a ghrelin mimetic, on postoperative ileus in bowel resection patients. Journal of Gastrointestinal Surgery, 18(6), 1063-1071. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/24700230/
  4. Gobburu, J.V., et al. (2011). Pharmacokinetics/pharmacodynamics of ipamorelin, a novel growth hormone secretagogue, in healthy volunteers. Journal of Clinical Pharmacology, 51(3), 311-320. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/20484613/
  5. Stier, H., et al. (2013). Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans. Journal of Endocrinology and Metabolism, 3(1-2), 7-15. [Online].
    Available: https://jofem.org/index.php/jofem/article/view/157/194

Related products